Imexhs Ltd · ASX:IME
Imexhs — Shareholder Meeting (April 2024)
44 slides from Imexhs's shareholder meeting presentation, Apr 23, 2024
Slide 1: 2024 Annual General Meeting – Chairman and CEO Addresses
23 April 2024 ASX ANNOUNCEMENT 2024 Annual General Meeting – Chairman and CEO Addresses For personal use only In accordance with ASX Listing Rule 3.13, attached are the Chairman and CEO Addresses together with the presentation slides, which will be delivered at the IMEXHS Limited Annual General Meet
Slide 2: Chairman's Address
IMEXHS Limited Annual General Meeting 23 April 2024 Chairman’s Address This AGM is on much earlier in the year than we would normally hold it. We did so because of the opportunity to align with the need to hold a meeting to approve the placement to directors and hold the AGM at the same time. That d
Slide 3: Chairman's Address: Capital Raise, Plan and Outlook
difficulty in passing on those costs. That said, the hospital out-sourced business model for radiology remains entirely relevant and growing. Our management team has a clear pathway to improving radiology client profitability and is well focused on solving the slow payment behaviour which has caused
Slide 4: Chairman's Address: Mexico and Sales Teams
economy in Latam, an historically strong currency and well-developed public and private hospital systems Mexico is an attractive place for IMEXHS to grow. Our sales management teams have delivered strong and growing results and continue to develop the way they go about addressing the market opportun
Slide 5: CEO's Address
CEO’s Address I am honoured to address you at this year's Annual General Meeting for IMEXHS Ltd. As we reflect on the past year, 2023 marked a pivotal turning point for our company. Through a blend of strategic foresight and rigorous execution, we have not only achieved but also exceeded our key fin
Slide 6: Plan and Outlook for 2024
3. Advanced RIS-PACS Tools: We are enhancing our offerings with superior visualization capabilities, deeper AI integration, and comprehensive support tools that empower radiologists and improve productivity across our networks. Plan and Outlook for 2024 The current year promises to be one of acceler
Slide 7: Annual General Meeting April 2024
For personal use only Annual General Meeting 23 April 2024
Slide 8: Board of Directors
Board of Directors For personal use only Doug Flynn Carlos Palacio Dr Doug Lingard Damian Banks Dr German Arango Non-Executive Non-Executive Non-Executive Non-Executive CEO & Managing Chairman Director Director Director Director IMEXHS LTD (ASX:IME) | AGM 23 April 2024 2
Slide 9: Registration & Voting
For personal use only Registration & Voting 1. Log in or register at: 2. Click view and register 3. Record your vote. Once https://investor.automic.com.au/#/home your attendance for the you confirm it is lodged and meeting final To contact support: Call 1300 816 159 or open live chat from the Invest
Slide 10: Agenda
Agenda For personal use only 2024 AGM 1. Introductions 2. Chairman’s Address 3. CEO’s Address 4. Business of Meeting 5. Resolutions & Proxy Vote Results 4
Slide 11: Chairman's Address
For personal use only Chairman’s Address Doug Flynn
Slide 12: CEO's Address
For personal use only CEO’s Address Dr German Arango
Slide 13: One Company with two businesses democratising access to medical imaging expertise
One Company with two businesses aimed at democratising access to medical imaging For personal use only expertise Medical Imaging Software Radiology Services Provider of innovative, cloud-based, Outsourcing of imaging facilities AI medical imaging software and teleradiology to hospitals and solutions
Slide 14: Global footprint
Global footprint For personal use only Software 18 countries; 485 sites 3,184 radiologists 28 distributors in 15 countries Radiology Colombia, Spain and Mexico 35 radiology centres 150+ in-house radiologists 8
Slide 15: FY23 Financial Highlights
FY23 Financial Highlights For personal use only Sales Revenue Annual Recurring Underlying Revenue (ARR) 2 EBITDA3 Up 15% yoy $19.7m Up 27% yoy $25.0m Up $0.5m yoy $0.4m Up 11% on a constant Up 1% on a constant vs ($0.1m) currency basis1 currency basis 2H Revenue Closing cash Debt Up 23% vs 1H FY23 $
Slide 16: Business Highlights
Business Highlights For personal use only • The Company has demonstrated the scalability of the business across different geographies with an attractive product and disruptive business model and now is focused on generating positive earnings and cashflow. • Focus is on sales within Latin America and
Slide 17: FY23 Operational Highlights
FY23 Operational Highlights For personal use only • Signed a new 5-year Software as a Service • Two new radiology services contracts signed (SaaS) contract with Grupo Avidanti – Zentria. with Famisanar, Colombia’s fifth largest The contract is priced in USD, has a TCV of insurance provider, with a c
Slide 18: Product and Software Updates
Product and Software Updates For personal use only ● Radiology Information System ● Universal Viewer v6.2 Enhancements ➢ Achieved significant milestone - successfully ➢ Hanging protocols customisation tool feature, formulated a novel architecture, technology to improve radiologists’ experience. stac
Slide 19: Focus for FY24
Focus for FY24 For personal use only Software Radiology Services 1) Rolling out New Value Proposition 1) Margin expansion ○ Enhanced digital security ○ Service levels 2) Focus and growth in Ideal Client ○ Integrated AI Profile ○ Unique tools for Radiologist 3) Tighten working capital ➢ Targeted towa
Slide 20: FY24 Outlook
FY24 Outlook For personal use only Key drivers for revenue and earnings 2 guidance growth: • Revenue of $24.0 – $27.0m • Annualised Recurring Revenue (22% – 37% up vs FY23) recently contracted and contracted but not yet billing. • Underlying EBITDA of $1.5 - $3.5m (up vs $0.4m in • Current pipeline
Slide 21: Business of Meeting
For personal use only Business of Meeting
Slide 22: Resolutions & Proxy Vote Results
For personal use only Resolutions & Proxy Vote Results
Slide 23: Financial Report
Financial Report For personal use only To receive the financial report of the Company and the reports of the Directors and of the Auditors for the financial year ended 31 December 2023. Q&A
Slide 24: 1: Remuneration Report
Resolution 1: Remuneration Report For personal use only “That, for the purposes of section 250R(2) of the Corporations Act and for all other purposes, the Remuneration Report for the financial year ended 31 December 2023 as disclosed in the Company’s Annual Report be adopted.” Proxy votes For Agains
Slide 25: 2: Re-election of Director – Dr Douglas Lingard
Resolution 2: Re-election of Director – Dr Douglas Lingard For personal use only “That, for the purpose of Article 6.3(c) of the Constitution, ASX Listing Rule 14.4 and 14.5, and for all other purposes, Dr Douglas Lingard, a Director, retires by rotation, and being eligible, is re-elected as a Direc
Slide 26: 3: Re-election of Director – Mr Damian Banks
Resolution 3: Re-election of Director – Mr Damian Banks For personal use only “That, for the purpose of Article 6.3(c) of the Constitution, ASX Listing Rule 14.4 and 14.5, and for all other purposes, Mr Damian Banks, a Director, retires by rotation, and being eligible, is re-elected as a Director of
Slide 27: 4: Grant of Options to the Chief Executive Officer
Resolution 4: Grant of Options to the Chief Executive Officer For personal use only “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 113,571 Options to the Managing Director & CEO, Dr German Arango, under the Plan on the terms and condit
Slide 28: 5: Grant of Options to Non-Executive Director Mr Damian Banks
Resolution 5: Grant of Options to Non-Executive Director Mr Damian Banks For personal use only “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 27,945 Options to Non-Executive Director, Mr Damian Banks, under the Plan on the terms and co
Slide 29: 6: Grant of Options to Non-Executive Director Mr Douglas Flynn
Resolution 6: Grant of Options to Non-Executive Director Mr Douglas Flynn For personal use only “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 55,890 Options to Non-Executive Director, Mr Douglas Flynn, under the Plan on the terms and
Slide 30: 7: Grant of Options to Non-Executive Director Dr Doug Lingard
Resolution 7: Grant of Options to Non-Executive Director Dr Doug Lingard For personal use only “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 27,945 Options to Non-Executive Director, Dr Doug Lingard, under the Plan on the terms and co
Slide 31: 8: Grant of Options to Non-Executive Director Mr Carlos Palacio
Resolution 8: Grant of Options to Non-Executive Director Mr Carlos Palacio For personal use only “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 27,945 Options to Non-Executive Director, Mr Carlos Palacio, under the Plan on the terms an
Slide 32: 9: Approval of 10% Share Placement Capacity
Resolution 9: Approval of 10% Share Placement Capacity For personal use only "That, for the purposes of ASX Listing Rule 7.1A and for all other purposes, Shareholders approve the Company having additional capacity to issue Equity Securities up to 10% of the issued capital of the Company (at the time
Slide 33: 10: Ratification of Prior Issue of Securities – Placement
Resolution 10: Ratification of Prior Issue of Securities – Placement For personal use only “That, for the purposes of ASX Listing Rule 7.4 and for all other purposes, the Shareholders ratify the issue on 15 March 2024 of a total of 2,272,728 fully paid ordinary shares in the Company at an issue pric
Slide 34: 11: Issue of Shares to Mr Douglas Flynn under the Conditional Placement
Resolution 11: Approval of Issue of Shares to Mr Douglas Flynn under the Conditional Placement For personal use only “That approval be given for the purposes of ASX Listing Rule 10.11 and for all other purposes, for the issue of 90,909 fully paid ordinary shares in the Company at $0.55 per fully pai
Slide 35: 12: Issue of Shares to Mr Carlos Palacio under the Conditional Placement
Resolution 12: Approval of Issue of Shares to Mr Carlos Palacio under the Conditional Placement For personal use only “That approval be given for the purposes of ASX Listing Rule 10.11 and for all other purposes, for the issue of 90,909 fully paid ordinary shares in the Company at $0.55 per fully pa
Slide 36: 13: Issue of Shares to Mr Douglas Lingard under the Conditional Placement
Resolution 13: Approval of Issue of Shares to Mr Douglas Lingard under the Conditional Placement For personal use only “That approval be given for the purposes of ASX Listing Rule 10.11 and for all other purposes, for the issue of 90,909 fully paid ordinary shares in the Company at $0.55 per fully p
Slide 37: 14: Issue of Shares to Mr Damian Banks under the Conditional Placement
Resolution 14: Approval of Issue of Shares to Mr Damian Banks under the Conditional Placement For personal use only “That approval be given for the purposes of ASX Listing Rule 10.11 and for all other purposes, for the issue of 90,909 fully paid ordinary shares in the Company at $0.55 per fully paid
Slide 38: 15: Issue of Shares to Dr German Arango under the Conditional Placement
Resolution 15: Approval of Issue of Shares to Dr German Arango under the Conditional Placement For personal use only “That approval be given for the purposes of ASX Listing Rule 10.11 and for all other purposes, for the issue of 90,909 fully paid ordinary shares in the Company at $0.55 per fully pai
Slide 39: 16: Issue of Shares in lieu of Director fees to Mr Damian Banks
Resolution 16: Issue of Shares in lieu of Payment of Non- Executive Director fees to Mr Damian Banks For personal use only “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the issue of Shares to the non-executive Director, Mr Damian Banks, in lieu of
Slide 40: 17: Issue of Shares in lieu of Director fees to Mr Douglas Flynn
Resolution 17: Issue of Shares in lieu of Payment of Non- Executive Director fees to Mr Douglas Flynn For personal use only “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the issue of Shares to the non-executive Director, Mr Douglas Flynn, in lieu
Slide 41: 18: Issue of Shares in lieu of Director fees to Dr Douglas Lingard
Resolution 18: Issue of Shares in lieu of Payment of Non- Executive Director fees to Dr Douglas Lingard For personal use only “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the issue of Shares to the non-executive Director, Dr Douglas Lingard, in l
Slide 42: 19: Issue of Shares in lieu of Director fees to Mr Carlos Palacio
Resolution 19: Issue of Shares in lieu of Payment of Non- Executive Director fees to Mr Carlos Palacio For personal use only “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the issue of Shares to the non-executive Director, Mr Carlos Palacio, in lie
Slide 43: Disclaimer
Disclaimer For personal use only The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipie
Slide 44: Annual General Meeting April 2024
For personal use only Annual General Meeting 23 April 2024